You are here:Home-Chemical Inhibitors & Agonists-Tyrosine Kinase-EGFR-OBX02-011
OBX02-011

Chemical Structure : OBX02-011

CAS No.: 2349336-18-9

OBX02-011

Catalog No.: PC-47006Not For Human Use, Lab Use Only.

OBX02-011 is a potent, reversible, fourth-generation EGFR tyrosine kinase inhibitor (TKI) that overcomes the EGFR C797S mutation, inhibits triple mutants Del19/T790M/C797S and L858R/T790M/C797S with IC50 of 0.134 and 2.09 nM, respectively.

Packing Price Stock Quantity
10 mg $268 In stock
25 mg $458 In stock
50 mg $758 In stock
100 mg $1180 In stock
200 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

OBX02-011 is a potent, reversible, fourth-generation EGFR tyrosine kinase inhibitor (TKI) that overcomes the EGFR C797S mutation, inhibits triple mutants Del19/T790M/C797S and L858R/T790M/C797S with IC50 of 0.134 and 2.09 nM, respectively.
OBX02-011 occupied the ATP-binding site in a similar manner to WZ-4002.
OBX02-011 showed broad activity at low nanomolar concentrations against mutant EGFRs, more potent in Del19/T790M/C797S and L858R/T790M than in other EGFR mutations.
OBX02-011 was highly effective against EGFR triple mutations, and showed substantial selectivity compared with WT EGFR (IC50= 1471 nM in WT, 96.3 nM in Del19/T790M/C797S, and 94.8 nM in L858R/T790M/C797S) in Ba/F3 cell lines expressing EGFR.
OBX02-011 (25 mg/kg, i. p.) effectively inhibited tumor growth and EGFR activity, leading to enhanced survival in transgenic mouse models (EGFRL858R/T790M/C797S).

Physicochemical Properties

M.Wt 615.194
Formula C29H39ClN8O3S
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

N-(2-((5-chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)-N-methylmethanesulfonamide

References

1. Yun Jung Choi, et al. Cancer Res. 2022 Jun 14;canres.0394.2022-2-3 21:03:12.200.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: